Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

JHOP Print Edition

JHOP Weekly e‑Newsletter

I have reviewed and consent to the terms of JHOP's Privacy Policy, and JHOP has my permission to retain my information in its database, and to forward pertinent communications to me.

JHOP - Supplements

August 2022 Clinical Trials to Clinical Practice

Lung Cancer

2022 Midyear Review: Non–Small-Cell Lung Cancer

Faculty Perspectives: Through the Pharmacists’ Lens: A Deep Dive into the Practice Dynamics in Graft-versus-Host Disease

First-Line OPDIVO® (nivolumab) in Combination with Chemotherapy in Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Cancer, and Esophageal Adenocarcinoma

Chronic Lymphocytic Leukemia

Navigating Chronic Lymphocytic Leukemia (CLL): The Critical Importance of the First 90 Days

First-Line OPDIVO® (nivolumab) in Combination with Chemotherapy in Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Cancer, and Esophageal Adenocarcinoma

February 2022 Clinical Trials to Clinical Practice

2021 Year in Review: Advances in Dual Immunotherapy Cancer Treatments

2021 Midyear Review - Non–Small-Cell Lung Cancer

JHOP - Evolving Guidelines

Page 1 of 2
Results 1 - 10 of 15